These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 24300275)
1. [Expression pattern of inflammatory cytokines at various inflammatory levels of adamantinomatous craniopharyngioma]. Zhou J; Qi ST; Chen LG; Huang CR; You J; Zhang C; Pan J Zhonghua Yi Xue Za Zhi; 2013 Aug; 93(31):2499-501. PubMed ID: 24300275 [TBL] [Abstract][Full Text] [Related]
2. Does the calcification of adamantinomatous craniopharyngioma resemble the calcium deposition of osteogenesis/odontogenesis? Song-Tao Q; Xiao-Rong Y; Jun P; Yong-Jian D; Jin L; Guang-Long H; Yun-Tao L; Jian R; Xiang-Zhao L; Jia-Ming X Histopathology; 2014 Feb; 64(3):336-47. PubMed ID: 24387671 [TBL] [Abstract][Full Text] [Related]
3. Interleukin‑6 induces an epithelial‑mesenchymal transition phenotype in human adamantinomatous craniopharyngioma cells and promotes tumor cell migration. Zhou J; Zhang C; Pan J; Chen L; Qi ST Mol Med Rep; 2017 Jun; 15(6):4123-4131. PubMed ID: 28487953 [TBL] [Abstract][Full Text] [Related]
4. Molecular Analyses Reveal Inflammatory Mediators in the Solid Component and Cyst Fluid of Human Adamantinomatous Craniopharyngioma. Donson AM; Apps J; Griesinger AM; Amani V; Witt DA; Anderson RCE; Niazi TN; Grant G; Souweidane M; Johnston JM; Jackson EM; Kleinschmidt-DeMasters BK; Handler MH; Tan AC; Gore L; Virasami A; Gonzalez-Meljem JM; Jacques TS; Martinez-Barbera JP; Foreman NK; Hankinson TC; J Neuropathol Exp Neurol; 2017 Sep; 76(9):779-788. PubMed ID: 28859336 [TBL] [Abstract][Full Text] [Related]
5. Expression of enamel proteins and LEF1 in adamantinomatous craniopharyngioma: evidence for its odontogenic epithelial differentiation. Sekine S; Takata T; Shibata T; Mori M; Morishita Y; Noguchi M; Uchida T; Kanai Y; Hirohashi S Histopathology; 2004 Dec; 45(6):573-9. PubMed ID: 15569047 [TBL] [Abstract][Full Text] [Related]
6. Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma. Kato K; Nakatani Y; Kanno H; Inayama Y; Ijiri R; Nagahara N; Miyake T; Tanaka M; Ito Y; Aida N; Tachibana K; Sekido K; Tanaka Y J Pathol; 2004 Jul; 203(3):814-21. PubMed ID: 15221941 [TBL] [Abstract][Full Text] [Related]
7. Different keratin profiles in craniopharyngioma subtypes and ameloblastomas. Tateyama H; Tada T; Okabe M; Takahashi E; Eimoto T Pathol Res Pract; 2001; 197(11):735-42. PubMed ID: 11770017 [TBL] [Abstract][Full Text] [Related]
8. Effects of Simvastatin on Inflammatory Response and Biological Behaviour of Adamantinomatous Craniopharyngioma. Li W; Zhang Y; Zhuang Y; Chen R; Xiong Z; Li K; Liu F; Xu H; Li D; Peng J Neuroendocrinology; 2024; 114(10):934-949. PubMed ID: 38964285 [TBL] [Abstract][Full Text] [Related]
9. Xanthogranuloma of the sellar region: a clinicopathological entity different from adamantinomatous craniopharyngioma. Paulus W; Honegger J; Keyvani K; Fahlbusch R Acta Neuropathol; 1999 Apr; 97(4):377-82. PubMed ID: 10208277 [TBL] [Abstract][Full Text] [Related]
10. Clinical features and prognosis of pediatric infradiaphragmatic craniopharyngioma relative to the tumor inflammatory response. Peng J; Yang L; Pan J; Wang C; Nie J; Liu Y; Fan J; Zhou J; Qi S Pediatr Res; 2021 Apr; 89(5):1119-1125. PubMed ID: 32559758 [TBL] [Abstract][Full Text] [Related]
11. Nuclear beta-catenin accumulation associates with epithelial morphogenesis in craniopharyngiomas. Buslei R; Hölsken A; Hofmann B; Kreutzer J; Siebzehnrubl F; Hans V; Oppel F; Buchfelder M; Fahlbusch R; Blümcke I Acta Neuropathol; 2007 May; 113(5):585-90. PubMed ID: 17221204 [TBL] [Abstract][Full Text] [Related]
12. Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic target. Apps JR; Carreno G; Gonzalez-Meljem JM; Haston S; Guiho R; Cooper JE; Manshaei S; Jani N; Hölsken A; Pettorini B; Beynon RJ; Simpson DM; Fraser HC; Hong Y; Hallang S; Stone TJ; Virasami A; Donson AM; Jones D; Aquilina K; Spoudeas H; Joshi AR; Grundy R; Storer LCD; Korbonits M; Hilton DA; Tossell K; Thavaraj S; Ungless MA; Gil J; Buslei R; Hankinson T; Hargrave D; Goding C; Andoniadou CL; Brogan P; Jacques TS; Williams HJ; Martinez-Barbera JP Acta Neuropathol; 2018 May; 135(5):757-777. PubMed ID: 29541918 [TBL] [Abstract][Full Text] [Related]
13. Expression of aberrant beta-catenin and impaired p63 in craniopharyngiomas. Cao J; Lin JP; Yang LX; Chen K; Huang ZS Br J Neurosurg; 2010 Jun; 24(3):249-56. PubMed ID: 20128632 [TBL] [Abstract][Full Text] [Related]
14. [Growth of craniopharyngioma involving the third ventricular floor in relation to the hypothalamus]. Liu BG; Qi ST; Pan J; Peng YP; Fang LX Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):377-9. PubMed ID: 17425998 [TBL] [Abstract][Full Text] [Related]
15. Calretinin is expressed in the stroma of adamantinomatous craniopharyngioma and may induce calcification. Chaohu W; Yi L; Hai H; Hui Z; Jun P; Song-Tao Q Clin Neurol Neurosurg; 2015 Nov; 138():124-8. PubMed ID: 26319618 [TBL] [Abstract][Full Text] [Related]
16. Clinicopathological study on craniopharyngioma with sebaceous differentiation. Tsunoda S; Sakaki T; Tsutsumi A; Eguchi T; Takeshima T; Morimoto T; Hashimoto H; Kiriishi R; Nakamura M; Tsuzuki T Noshuyo Byori; 1993; 10(1):69-74. PubMed ID: 8220784 [TBL] [Abstract][Full Text] [Related]
17. Intraarticular and systemic inflammatory profiles may identify patients with osteoarthritis. Heard BJ; Fritzler MJ; Wiley JP; McAllister J; Martin L; El-Gabalawy H; Hart DA; Frank CB; Krawetz R J Rheumatol; 2013 Aug; 40(8):1379-87. PubMed ID: 23678161 [TBL] [Abstract][Full Text] [Related]
18. Radiosensitive squamous cell craniopharyngioma: clinical and pathological comparison with the adamantinomatous type. Inoue HK; Nakamura M; Ono N; Kohga H; Kakegawa T; Naitou I; Tamada J; Handa I Noshuyo Byori; 1993; 10(1):27-31. PubMed ID: 8220780 [TBL] [Abstract][Full Text] [Related]
19. [Inflammatory cytokine expression in recurrent nasal polyps by antibody chips]. Chen Y; Sun H; Liu H; Chen X Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Nov; 34(11):1086-90. PubMed ID: 19952397 [TBL] [Abstract][Full Text] [Related]
20. [Expression of proliferating cell nuclear antigen in craniopharyngioma and tumor recurrence]. Pan J; Qi ST; Deng YJ; Ding YQ; Peng L; Li XQ Di Yi Jun Yi Da Xue Xue Bao; 2002 Apr; 22(4):363-5. PubMed ID: 12390748 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]